University Of Guadalajara
Clinical trials sponsored by University Of Guadalajara, explained in plain language.
-
New study aims to find best CMV prevention for kidney transplant patients
Disease control OngoingThis study looks at 68 adults who received a kidney transplant from a living donor and are at intermediate risk for CMV infection. It compares two approaches: giving valganciclovir as a preventive treatment versus waiting to treat only if CMV is detected. The goal is to see which…
Phase: PHASE4 • Sponsor: University of Guadalajara • Aim: Disease control
Last updated May 09, 2026 05:34 UTC
-
Can a common diabetes pill save transplanted kidneys?
Disease control OngoingThis study tests whether dapagliflozin, a drug used for diabetes, can help protect kidney function in people who received a kidney transplant from a living donor. About 54 adults will take the drug daily for a year, starting one month after transplant, and their kidney health wil…
Phase: PHASE2 • Sponsor: University of Guadalajara • Aim: Disease control
Last updated May 08, 2026 12:02 UTC